Table 3.
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
HR (95% CI) | p- value | HR (95% CI) | p- value | HR (95% CI) | p- value | |
All-cause mortality | ||||||
Phosphorus (mmol/L) | 0.81 (0.67–0.98) | 0.03 | 1.07 (0.89–1.29) | 0.48 | 0.71 (0.45–1.14) | 0.16 |
Albumin (g/L) | 0.92 (0.91–0.94) | <0.001 | 0.96 (0.94–0.97) | <0.001 | 0.93 (0.89–0.98) | 0.003 |
Interaction | <0.001 | 0.03 | 0.02 | |||
Cardiovascular mortality | ||||||
Phosphorus (mmol/L) | 0.83 (0.63–1.10) | 0.83 | 1.11 (0.85–1.45) | 0.45 | 0.75 (0.49–1.14) | 0.18 |
Albumin (g/L) | 0.94 (0.92–0.96) | <0.001 | 0.97 (0.95–0.99) | 0.01 | 0.95 (0.91–0.99) | 0.03 |
Interaction | 0.001 | 0.32 | 0.02 |
HR, hazard ratio.
*Bold indicates significance at p < 0.05.
Model 1 unadjusted.
Model 2 adjusted for: age and gender.
Model 3 adjusted: model 2+ history of diabetes and cardiovascular disease, serum levels of hemoglobin, high sensitive C-reactive protein, intact parathyroid hormone, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low-density lipoprotein cholesterol, residual renal function, and uses of phosphate binders, calcitriol, and α-ketoacid.